CD8A and breast cancer: CD8 T-sEVs containing AXL-siRNA (siAXL) loaded glutathione (GSH)-responsive PTX-poly-L-lysine (PTX-PLL; PP) prodrug micelle were found to induce paclitaxel (PTX) release which then destroyed breast cancer cells [92].